1-5 of 5
Authors: James O. Armitage
Save search
Sort by
Journal Article

Primum succurrere; first hasten to help Open Access

PDF
Dan L Longo and James O Armitage
The Oncologist, Volume 30, Issue 4, April 2025, oyae368, https://doi.org/10.1093/oncolo/oyae368
Published: 11 April 2025
Journal Article

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions Free

PDF
Charles L. Bennett and others
The Oncologist, Volume 26, Issue 8, August 2021, Pages e1418–e1426, https://doi.org/10.1002/onco.13713
Published: 12 March 2021
Journal Article

Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada Free

PDF
Brian Chen and others
The Oncologist, Volume 24, Issue 4, April 2019, Pages 537–548, https://doi.org/10.1634/theoncologist.2018-0341
Published: 06 March 2019
Journal Article

High-Dose Therapy in Lymphomas: A Review of the Current Status of Allogeneic and Autologous Stem Cell Transplantation in Hodgkin's Disease and Non-Hodgkin's Lymphoma Free

PDF
Scott A. Mink and James O. Armitage
The Oncologist, Volume 6, Issue 3, June 2001, Pages 247–256, https://doi.org/10.1634/theoncologist.6-3-247
Published: 01 June 2001
Journal Article

Bone Marrow Transplantation for Cancer—An Update Free

PDF
Z. Steven Pavletic and James O. Armitage
The Oncologist, Volume 1, Issue 3, June 1996, Pages 159–168, https://doi.org/10.1634/theoncologist.1-3-159
Published: 01 June 1996